Nicole S. White - Sep 13, 2023 Form 3 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Role
Chief Manufacturing Officer
Signature
/s/ John O. Gunderson, as Attorney-in-Fact
Stock symbol
ASMB
Transactions as of
Sep 13, 2023
Transactions value $
$0
Form type
3
Date filed
9/18/2023, 06:34 PM
Next filing
Oct 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ASMB Common Stock 86.1K Sep 13, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ASMB Stock Option (right to buy) Sep 13, 2023 Common Stock 50K $5.62 Direct F2
holding ASMB Stock Option (right to buy) Sep 13, 2023 Common Stock 100K $2.30 Direct F3
holding ASMB Stock Option (right to buy) Sep 13, 2023 Common Stock 200K $2.01 Direct F4
holding ASMB Stock Option (right to buy) Sep 13, 2023 Common Stock 140K $0.89 Direct F5
holding ASMB Performance-based Restricted Stock Units Sep 13, 2023 Common Stock 25K $0.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include grants of restricted stock units (RSUs) vesting, in each case assuming continuous service on each vesting date, as follows: (a) 2,500 RSUs vesting in equal installments on November 16, 2023 and November 16, 2024; (b) 18,750 RSUs vesting in equal installments on March 29, 2024, March 29, 2025 and March 29, 2026; (c) 5,469 RSUs vesting on May 22, 2024; and (d) 25,000 RSUs vesting on August 1, 2024.
F2 Grant of stock options. Options to purchase 34,375 shares of common stock have vested, and, assuming continuous service on each vesting date, the remaining stock options vest in 15 approximately equal monthly installments, with the options becoming fully vested on November 16, 2024.
F3 Grant of stock options. Options to purchase 35,416 shares of common stock have vested, and, assuming continuous service on each vesting date, the remaining stock options vest in 31 approximately equal monthly installments, with the options becoming fully vested on March 29, 2026.
F4 Grant of stock options. Options to purchase 54,166 shares of common stock have vested, and, assuming continuous service on each vesting date, the remaining stock options vest in 35 approximately equal monthly installments, with the options becoming fully vested on August 1, 2026.
F5 Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2024; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2027.
F6 Each performance-based RSU represents a contingent right to receive one share of the Issuer's common stock. The shares are earned if either of two trading price metrics are met (each a "Stock Metric") either on or before the second or on or before the fourth anniversary of the grant date, as applicable. If a Stock Metric is met on or before the first anniversary of the grant date, then 50% of the RSUs vest on the first anniversary of the grant date and the remainder will vest on the second anniversary of the grant date. If a Stock Metric is achieved after the first anniversary of the grant date and on or before the fourth anniversary of the grant date, then 50% of the RSUs vest on the date that the Stock Metric is achieved and the remaining 50% of the RSUs vest on the first anniversary of the initial vesting date. Special vesting provisions apply in the case of a change in control transaction.

Remarks:

Exhibit 24.1 - Power of Attorney